Active suppression in orally tolerized rats coincides with in situ transforming growth factor-beta (TGF-β) expression in the draining lymph nodes

Clinical and Experimental Immunology

Volumn 116, Issue 1, 1999, Pages 181-187

  Lundin, B S ^a   Karlsson, M R ^a   Svensson, L A ^a   Hanson, L Å ^a   Dahlgren, U I H ^a   Telemo, E ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

High dose; Oral tolerance; Transforming growth factor beta

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; LYMPH NODE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE SUBPOPULATION;

ADMINISTRATION, ORAL; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; EATING; HINDLIMB; IMMUNE TOLERANCE; IMMUNIZATION; INJECTIONS, SUBCUTANEOUS; LYMPH NODES; MALE; OVALBUMIN; RATS; RATS, WISTAR; RNA, MESSENGER; SERUM ALBUMIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032933740     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00834.x     Document Type: Article

References (26)

1. 1 Kagnoff MF. Effects of antigen-feeding on intestinal and systemic immune responses, II, Suppression of delayed type hypersensitivity reactions. J Immunol 1978; 120:1509-13.
2. 2 Hanson DG, Vaz NM, Maia L et al. Inhibition of specific immune responses by feeding protein antigens. Int Arch Allergy Appl Immun 1977; 55:526-32.
3. 3 Thomas HC, Parrot D. The induction of tolerance to a soluble protein antigen by oral administration. Immunology 1974; 27:631-9.
4. 4 Melamed D, Friedman A. Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol 1993; 23:935-42.
5. 5 Melamed D, Friedman A. In vivo tolerization of Th1 lymphocytes following a single feeding with ovalbumin: anergy in the absence of suppression. Eur J Immunol 1994; 24:1974-81.
6. 6 Whitacre CC, Gienapp IE, Orosz CG et al. Oral tolerance in experimental autoimmune encephalomyelitis III. Evidence for clonal anergy. J Immunol 1991; 147:2155-63.
7. 7 Chen Y, Inobe J, Marks R et al. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995; 376:177-80.
8. 8 Miller A, Lider O, Roberts AB et al. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci USA 1992; 89:421-5.
9. 9 Miller SR, Hanson D. Inhibition of specific immune responses by feeding protein antigens IV. Evidence for tolerance and specific active suppression of cell mediated immune responses to ovalbumin. J Immunol 1979; 123:2344-50.
10. 10 Dahlman-Höglund A, Dahlgren U, Ahlstedt S et al. Bystander suppression of the immune response to human serum albumin in rats fed ovalbumin. Immunology 1995; 86:128-33.
11. 11 Friedman A, Weiner HL. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 1994; 91:6688-92.
12. 12 Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997; 18:335-43.
13. 13 Gregerson DS, Obritsch WF, Donoso LA. Oral tolerance in experimental autoimmune uveoretinitis: distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol 1993; 151:5751-61.
14. 14 Lundin BS, Dahlgren UI, Hanson LÅ et al. Oral tolerization leads to active suppression and bystander tolerance in adult rats while anergy dominates in young rats. Scand J Immunol 1996; 43:56-63.
15. 15 Mowat AM, Steel M, Worthey EA et al. Inactivation of Th1 and Th2 cells by feeding ovalbumin. Ann N Y Acad Sci 1996; 778:122-32.
16. 16 Marth T, Strober W, Kelsall BL. High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. J Immunol 1996; 157:2348-57.
17. 17 Chen Y, Kuchroo VK, Inobe J et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994; 265:1237-40.
18. 18 Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992; 176:1355-64.
19. 19 Wold AE, Dahlgren UIH, Hanson LÅ et al. Difference between bacterial and food antigens in mucosal immunogenicity. Infect Immun 1989; 57:2666-73.
20. 20 Matsuda S, Uchikawa R, Yamada M et al. Cytokine mRNA expression profiles in rats infected with the intestinal nematode Nippostrongylus brasiliensis. Infect Immun 1995; 63:4653-60.
21. 21 Gray JD, Hirokawa M, Ohtsuka K et al. Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3. J Immunol 1998; 160:2248-54.
22. 22 Groux H, O'Garra A, Bigler M et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389:737-42.
23. 23 Gonnella PA, Chen Y, Inobe J et al. In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice. J Immunol 1998; 160:4708-18.
24. 24 Coffman RL, Lebman DA, Shrader B. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med 1989; 170:1039-44.
25. 25 Haneda K, Sano K, Tamura G et al. TGF-beta induced by oral tolerance ameliorates experimental tracheal eosinophilia. J Immunol 1997; 159:4484-90.
26. 26 Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6:597-641.